The efficiency of self-monitoring the activity of a process in rheumatoid arthritis in outpatient practice

DOI: https://doi.org/10.29296/25877305-2019-05-13
Download full text PDF
Issue: 
5
Year: 
2019

E. Yurova; E. Lygina, Candidate of Medical Sciences; Professor N. Nikulina, MD; Professor S. Yakushin, MD Acad. I.P. Pavlov Ryazan State Medical University

The positive experience has been gained with self-monitoring by patients of their status in many chronic noncommunicable diseases: diabetes, hypertensive disease, asthma, etc. Such monitoring can be carried out for a long time without seeking medical advice. A methodology for self-monitoring of disease activity in rheumatoid arthritis (RA) is just coming under study; the results obtained are contradictory. The paper evaluates the efficiency of using a structured procedure for self-determination of RA activity by a patient at home. Two groups of patients with RA were formed. These were: 1) those who were trained in self-monitoring techniques (n = 30); 2) those who were untrained (n = 30). The follow-up lasted 6 months. The proposed procedure for self-monitoring allowed patients to monitor RA activity for 6 months after training is not worse than the traditional monthly physician monitoring, which enables it to be recommended for use in outpatient practice.
Keywords: 
rheumatology
rheumatoid arthritis
outpatient attendance
self-monitoring
patient education

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Petrun'ko I.L., Men'shikova L.V., Sergeeva L.V. i dr. Zabolevanija kostno-myshechnoj sistemy i soedinitel'noj tkani: invalidnost' v Irkutskoj oblasti v 2013–2015 gg. // Nauchno-prakticheskaja revmatologija. – 2017; 55 (1): 54–7 [Petrunko I.L., Menshikova L.V., Sergeeva N.V. et al. Musculoskeletal and connective tissue diseases: disability in the irkutsk region in 2013–2015 // Rheumatology Science and Practice. – 2017; 55 (1): 54–7 (In Russ.)]. https://doi.org/10.14412/1995-4484-2017-54-57.
  2. Pechenkina S.N. Analiz zabolevaemosti s vremennoj utratoj trudosposobnosti v Rjazanskoj oblasti // Nauka molodyh (Eruditio Juvenium). – 2018; 6 (3): 383–7 [Pechenkina S.N. Analysis of morbidity with temporary disability in the Ryazan region // Science of the Young (Eruditio Juvenium). – 2018; 6 (3): 383–7 (In Russ)]. DOI: 10.23888/HMJ201863383-387.
  3. Yelin E., Trupin L., Wong B. et al. The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis // J. Rheumatol. – 2002; 29: 1851–7.
  4. Wolfe F., Michaud K., Gefeller O. et al. Predicting mortality in patients with rheumatoid arthritis // Arthritis & Rheumatology. – 2003; 48: 1530–42. DOI: 10.1002/art.11024.
  5. Smolen J., van Der Heijde D., St Clair E. et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial // Arthritis & Rheumatology. – 2006; 54 (3): 702–10. DOI: 10.1002/art.21678.
  6. Furst D., Keystone E., Kirkham B. et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases. // Ann. Rheum. Diseases. – 2008; 67: 1112–25. DOI: 10.1136/ard.2009.123885.
  7. Karateev D.E. Nizkaja aktivnost' i remissija pri revmatoidnom artrite: klinicheskie, immunologicheskie i morfologicheskie aspekty // Nauchno-prakticheskaja revmatologija. – 2009; 5: 4–13 [Karateev D.E. Low activity and remission in rheumatoid arthritis. Clinical, immunological and morphological aspects // Rheumatology Science and Practice. – 2009; 47 (5): 4–12 (In Russ.)] https://doi.org/10.14412/1995-4484-2009-582.
  8. Nasonov E.L., Karateev D.E., Chichasova N.V. Novye rekomendatsii po lecheniju revmatoidnogo artrita (EULAR, 2013): mesto metotreksata // Nauchno-prakticheskaja revmatologija. – 2014; 52 (1): 8–26 [Nasonov E.L., Karateev D.E., Chichasova N.V. New recommendations for the management of rheumatoid arthritis (eular, 2013): the role of methotrexate // Rheumatology Science and Practice. – 2014; 52 (1): 8–26 (In Russ.)]. https://doi.org/10.14412/1995-4484-2014-8-26.
  9. Filippov E.V. Monitoring povedencheskih faktorov riska hronicheskih neinfektsionnyh zabolevanij v 2014 godu // Rossijskij mediko-biologicheskij vestnik im. akad. I.P. Pavlova. – 2015; 1: 72–83 [Filippov E.V. Monitoring behavioral risk factors for chronic noncommunicable diseases in 2014 // Russian Medical and Biological Bulletin named after academician I.P. Pavlova. – 2015; 1: 72–83 (in Russ.)].
  10. Ratova L.G., Chazova I.E. Samokontrol' arterial'nogo davlenija // Consilium Medicum. – 2007; 11: 45–8 [Ratova L.G., Chazova I.E. Self-monitoring of blood pressure // Consilium Medicum. – 2007; 11: 45–8 (in Russ.)].
  11. Dreval' A.V., Red'kin Ju.A. Rol' samokontrolja v lechenii saharnogo diabeta // Russkij meditsinskij zhurnal. – 2016; 1: 38–40 [Dreval A.V., Redkin Yu.A. The role of self-control in the treatment of diabetes mellitus // Russkiy meditsinskiy zhurnal. – 2016; 1: 38–40 (in Russ.)]
  12. Barton J., Criswell L., Kaiser R. et al. Systematic Review and Metaanalysis of Patient Self-Report versus Trained Assessor Joint Counts in Rheumatoid Arthritis // J. Rheumatol. – 2009; 36 (12): 2635–41. DOI: 10.3899/jrheum.090569.
  13. Dougados M., Soubrier M., Perrodeau E. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA) // Ann. Rheum. Diseases. – 2015; 74 (9): 1725–33. DOI: 10.1136/annrheumdis-2013-204733.
  14. Lygina E.V., Pron'kina E.V., Jakushin S.S. Strukturirovannaja programma obuchenija bol'nyh revmatoidnym artritom samostojatel'nomu monitoringu aktivnosti zabolevanija // Nauchno-prakticheskaja revmatologija. – 2014; 52 (1): 37–43 [Lygina E.V., Pron’kina E.V., Yakushin S.S. A structured training program for patients with rheumatoid arthritis to self-monitor disease activity // Rheumatology Science and Practice. – 2014; 52 (1): 37–43 (In Russ.)]. DOI: 10.14412/1995-4484-2014-37-43.
  15. Nasonov E.L., Karateev D.E., Chichasova N.V. Rekomendatsii EULAR po lecheniju revmatoidnogo artrita – 2013: obschaja harakteristika i diskussionnye problemy. // Nauchno-prakticheskaja revmatologija. – 2013; 51 (6): 609–22 [Nasonov E.L., Karateev D.E., Chichasova N.V. EULAR recommendations for the treatment of rheumatoid arthritis – 2013: general characteristics and disputable problems // Rheumatology Science and Practice. – 2013; 51 (6): 609–22 (In Russ.)]. https://doi.org/10.14412/1995-4484-2013-609-22.
  16. Orlova E.V., Karateev D.E. Effektivnost' obuchenija bol'nyh revmatoidnym artritom na rannej stadii zabolevanija. // Sovremennaja revmatologija. – 2014; 8 (4): 25–32 [Orlova E.V., Karateev D.E. Efficiency of teaching patients with early-stage rheumatoid arthritis // Modern Rheumatology Journal. – 2014; 8 (4): 25–32 (In Russ.)]. DOI: 10.14412/1996-7012-2014-4-25-32.
  17. Levy G., Cheetham C., Cheatwood A. et al. Validation of patient-reported joint counts in rheumatoid arthritis and the role of training // J. Rheumatol. – 2007; 34: 1261–5.